BPG is committed to discovery and dissemination of knowledge
Articles Published Processes
8/26/2014 9:28:00 AM | Browse: 958 | Download: 840
Publication Name World Journal of Orthopedics
Manuscript ID 7413
Country Italy
Received
2013-11-17 07:44
Peer-Review Started
2013-11-18 15:48
To Make the First Decision
2013-12-10 14:31
Return for Revision
2013-12-17 16:16
Revised
2013-12-31 01:03
Second Decision
2014-05-29 15:49
Accepted by Journal Editor-in-Chief
Accepted by Company Editor-in-Chief
2014-05-29 15:58
Articles in Press
2014-05-29 15:58
Publication Fee Transferred
Edit the Manuscript by Language Editor
Typeset the Manuscript
2014-07-01 09:05
Publish the Manuscript Online
2014-07-19 23:48
ISSN 2218-5836 (online)
Open Access
Copyright
Article Reprints For details, please visit: http://www.wjgnet.com/bpg/gerinfo/247
Permissions For details, please visit: http://www.wjgnet.com/bpg/gerinfo/207
Publisher Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA
Website http://www.wjgnet.com
Category Endocrinology & Metabolism
Manuscript Type Topic Highlights
Article Title Bone anabolics in osteoporosis: Actuality and perspectives
Manuscript Source Invited Manuscript
All Author List Andrea Montagnani
Funding Agency and Grant Number
Corresponding Author Andrea Montagnani, MD, PhD, Metabolic Bone Diseases Area, Department of Internal Medicine, Misericordia Hospital, Via Senese, 169, 58100 Grosseto, Italy. montagnaniand@gmail.com
Key Words Anabolic therapy; Bone mass; Bone fracture; Osteoporosis
Core Tip The study of agents active on bone formation is the main objective in the treatment of severe osteoporosis. rhparathyroid hormone (rhPTH) decreases vertebral, but not nonvertebral, fractures. On the contrary, antagonists of Wnt-inhibitors, that exert their effects mostly through a bone remodeling-independent mechanism, open new perspectives to improve not only trabecular bone but also cortical bone, with potential positive effect also on nonvertebral fractures incidence. The perspective in osteoporosis treatment should be more effective and better tolerated therapies aimed at minimizing individually fractures risk.
Publish Date 2014-07-19 23:48
Citation Montagnani A. Bone anabolics in osteoporosis: Actuality and perspectives. World J Orthop 2014; 5(3): 247-254
URL http://www.wjgnet.com/2218-5836/full/v5/i3/247.htm
DOI http://dx.doi.org/10.5312/wjo.v5.i3.247
Full Article (PDF) WJO-5-247.pdf
Full Article (Word) WJO-5-247.doc
Manuscript File 7413-Review.docx
Answering Reviewers 7413-Answering reviewers.pdf
Copyright License Agreement 7413-Copyright assignment.pdf
Peer-review Report 7413-Peer review(s).pdf
Scientific Misconduct Check 7413-CrossCheck.jpg
Scientific Editor Work List 7413-Scientific editor work list.pdf